Next Article in Journal
The Peculiar Glycolytic Pathway in Hyperthermophylic Archaea: Understanding Its Whims by Experimentation In Silico
Next Article in Special Issue
Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis
Previous Article in Journal
Roles of Copper-Binding Proteins in Breast Cancer
Previous Article in Special Issue
Sus scrofa miR-204 and miR-4331 Negatively Regulate Swine H1N1/2009 Influenza A Virus Replication by Targeting Viral HA and NS, Respectively
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 18
Issue 4
10.3390/ijms18040869
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants

by
Siddharth Sridhar
1,
Jade L. L. Teng
1,2,3,4,
Tsz-Ho Chiu
1,
Susanna K. P. Lau
1,2,3,4 and
Patrick C. Y. Woo
1,2,3,4,*
1
Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
2
State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, University Pathology Building, Queen Mary Hospital, Hong Kong, China
3
Research Centre of Infection and Immunology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
4
Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(4), 869; https://doi.org/10.3390/ijms18040869
Submission received: 27 March 2017 / Revised: 11 April 2017 / Accepted: 18 April 2017 / Published: 20 April 2017
(This article belongs to the Special Issue Molecular Research of Emerging Viruses: Viral Evolution, Diagnostics and Pathogenesis and Therapeutics)
Browse Figures
Versions Notes

Abstract

:
Hepatitis E virus (HEV) is a major cause of viral hepatitis globally. Zoonotic HEV is an important cause of chronic hepatitis in immunocompromised patients. The rapid identification of novel HEV variants and accumulating sequence information has prompted significant changes in taxonomy of the family Hepeviridae. This family includes two genera: Orthohepevirus, which infects terrestrial vertebrates, and Piscihepevirus, which infects fish. Within Orthohepevirus, there are four species, A–D, with widely differing host range. Orthohepevirus A contains the HEV variants infecting humans and its significance continues to expand with new clinical information. We now recognize eight genotypes within Orthohepevirus A: HEV1 and HEV2, restricted to humans; HEV3, which circulates among humans, swine, rabbits, deer and mongooses; HEV4, which circulates between humans and swine; HEV5 and HEV6, which are found in wild boars; and HEV7 and HEV8, which were recently identified in dromedary and Bactrian camels, respectively. HEV7 is an example of a novel genotype that was found to have significance to human health shortly after discovery. In this review, we summarize recent developments in HEV molecular taxonomy, epidemiology and evolution and describe the discovery of novel camel HEV genotypes as an illustrative example of the changes in this field.

1. Introduction

Hepatitis E virus (HEV) is an important cause of both epidemic and sporadic viral hepatitis. HEV has been estimated to cause 3.3 million symptomatic cases of acute hepatitis worldwide [1] and in some areas has overtaken hepatitis A as the most common cause of acute viral hepatitis [2]. Although most cases are self-limiting, pregnant women, in particular, have a propensity to progress to fulminant hepatitis [3]. Furthermore, immunocompromised patients such as transplant recipients, patients with hematological malignancies and advanced HIV may progress to chronic hepatitis following an HEV infection [4,5,6].
The global distribution of human disease due to HEV relies partly on its “two-faced” epidemiology. In hyperendemic areas, hepatitis E is often linked to contamination of water supplies with human fecal material and represents person-to-person transmission [7]. However, in low endemic areas with high socioeconomic development, hepatitis E is predominantly a foodborne zoonosis, which is most commonly transmitted to humans consuming undercooked pork products [7,8]. In addition to pork, hepatitis E has also been transmitted to humans consuming meat or milk of feral animals including wild boar, deer, rabbits and camels [9,10,11,12,13].
The basis for this contrasting epidemiology lies in the phylogenetic diversity of HEV. Our knowledge of HEV diversity is constantly evolving with the discovery of novel HEV variants in various animal hosts around the world. With the accumulation of high-quality genomic information, HEV taxonomy has undergone significant changes recently to reflect the diversity of this family of viruses. Sophisticated sequence analyses have been possible to address various questions related to the molecular epidemiology and evolution of HEV. The objective of this review is to provide an update on the molecular basis of modern HEV taxonomy along with a summary of recent advances in HEV epidemiology and evolution. The discovery of camelid HEV genotypes and recognition of their importance to human health is used as an illustrative example of recent changes in this field.

2. HEV Genomic Organization

HEV is a nonenveloped virus with a 27–34 nm, T = 1 icosahedral capsid enclosing the viral genome. The single-stranded, positive-sense RNA genome varies from 6.6 to 7.3 kB in length; similar to eukaryotic mRNA, the 5′ end has a 7-methylguanylate (m7G) cap while the 3′ end is polyadenylated [14]. Short untranslated regions flank three open reading frames (ORFs), which are named ORF1, ORF2 and ORF3 in a 5′→3′ direction. Overlapping reading frames ORF2 and ORF3 encode for frameshifted products from a bicistronic subgenomic mRNA species [15]. There is inter-species variation in the location of the ORF2/ORF3 junction with the divergent variant cutthroat trout virus having an ORF3 that is displaced towards the middle of ORF2 (Figure 1).
ORF1 is the longest of the three reading frames, accounting for nearly two-thirds of the entire genome [14]. It encodes a non-structural polyprotein that possesses several functional domains critical for viral replication [16]. There is still controversy regarding whether the ORF1 product undergoes any post-translational proteolytic processing [17]. Functionally characterized domains of ORF1 include a methyltransferase, helicase and RNA-dependent RNA polymerase (RdRp). Computational analysis of ORF1 also reveals a papain-like cysteine protease, macro and hypervariable domains. The exact role of these domains in the HEV replication cycle remains speculative and may indirectly be inferred by homologous domains in other positive-sense RNA viruses [16].
The ORF2 region on the 2.2 kB m7G capped subgenomic RNA (sgRNA) species encodes the viral capsid protein, which is important for viral entry and also contains immunological epitopes for antibody targets [17]. The ORF3 region is also expressed from the same sgRNA species and the start codons of ORF2 and ORF3 are only separated by only a few nucleotides [14]. The ORF3 encoded phosphoprotein has been observed to interact with the cellular cytoskeleton and endosomal system and is tentatively believed to play a role in viral egress [18,19].

3. Hepatitis E Virus (HEV) Taxonomy: In Constant Evolution

HEV is difficult to culture from clinical specimens, animal models are not widely available and several HEV variants from diverse epidemiological sources appear to have broadly cross-reactive antigenicity [20,21,22,23]. Therefore, from an early stage, the genetic characteristics of HEV variants were the main basis for taxonomic classification as opposed to other viral families where serotyping and cell culture characteristics played an important role in early classification schema. Classifications of HEV using genetic methods also closely mirror ecology and zooepidemiology of virus variants proving the fundamental soundness of this technique. However, as more sequence information from divergent isolates became available, there was considerable confusion due to the proliferation of differing classification schemes based on methods such as nucleotide identities, genetic distances, amino acid identities, phylogenetic analysis, PCR-restriction fragment length polymorphism, and ORF structure of different areas of the genome [24,25,26,27,28,29,30,31]. Indeed, the very definition of various taxons within Hepeviridae has undergone continuous evolution to reflect the emerging diversity of the family.
Originally included as a member of the family Caliciviridae, HEV was reassigned to the newly-created family Hepeviridae in 2009 by the International Committee on Taxonomy of Viruses (ICTV). According to the current taxonomy release (2015), the family Hepeviridae includes two genera: Orthohepevirus and Piscihepevirus [32]. The former encompasses all mammalian and avian HEV variants while the latter includes the highly divergent cutthroat trout virus placed within a single species. The Orthohepevirus genus is further subdivided into four species (A–D). The current consensus proposals for classification of the family Hepeviridae adopted by ICTV were put forward by Smith et al. in 2014 [27,32].
Division of the family into the two aforementioned genera was made straightforward by the clear genetic differences of Piscihepevirus A, the sole species within the Piscihepevirus genus, from other HEV belonging to the Orthohepevirus genus: ORF3 of cutthroat trout virus (the only virus within the Piscihepevirus genus so far) is displaced far towards the middle of ORF2 (Figure 1) compared to members of the Orthohepevirus genus, and comparative inter-genus p-distances of even functionally significant (i.e., highly conserved) amino acid sequences encoded by ORF1 like methyltrasferase, helicase and polymerase exceed 0.55 [27,33]. Furthermore, overall sequence identities of ORF2 and ORF3 between cutthroat trout virus and other members of the Hepeviridae family are only 18–21% and 13‒16%, respectively. In comparison, amino acid sequence similarities of ORF2 and ORF3 between avian and mammalian HEV in the Orthohepevirus genus are 42‒55% and 20‒29%, respectively [27]. Table 1 also illustrates other differences in genomic organization between cutthroat trout virus and other HEV types with reference to the newly discovered HEV8 camelid genotype. This extreme phylogenetic divergence is reflected in the ecology of Piscihepevirus, which infects fish, in contrast to other members of the family Hepeviridae, which infect terrestrial vertebrates.

4. Beyond the Species Level: HEV Genotypes and Subgenotypes

Classification below the species level is beyond the aegis of ICTV; however, guidance on further classification into genotypes have also been proposed by Smith et al. [27]. Much of these classification efforts have focused on Orthohepevirus A, which is the most diverse species and contains several genotypes pathogenic to humans. Based on pairwise amino acid sequence comparisons of available concatenated ORF1 and ORF2 sequences (excluding the ORF1 hypervariable region) of HEV variants visualized using a p-distance frequency distribution histogram, a p-distance of 0.088 appears to mark the demarcation between intra-genotypic and inter-genotypic sequence diversity [27]. A p-distance greater than this threshold is, therefore, used as the definition of novel genotypes and this system enables classification of Orthohepevirus A into eight genotypes. However, the significant sequence diversity within this species appears to be a continuum and the future discovery of variants that challenge fixed definitions of genotype can be anticipated. The identification of inter-genotypic HEV recombinants infecting swine [31,34] further complicates precise genotype allocations of all strains.
Individual genotypes within Orthohepevirus A are often congruent with well-defined geographical distribution and host restriction although inter-species transmission of particular HEV genotypes has been well documented in both laboratory and field settings [35]. Genotypes 1–4 are most commonly implicated in human infection with contrasting epidemiology. Genotype 1 HEV (HEV-1) only infects humans and is the most common cause of hepatitis E in regions with lower socioeconomic development where it is predominantly spread via contaminated potable water. Genotype 2 HEV (HEV-2) appears to be very rare, the only complete genome sequence comes from a strain identified in Mexico; based on short fragments, some HEV variants identified in Africa may belong to HEV-2 as well [36,37]. HEV-3 and HEV-4 circulate in swine populations (including pigs and wild boar) and are an important cause of zoonotic foodborne autochthonous human hepatitis E in areas with high socioeconomic development [38]. HEV-3 is enzootic in the Americas, Europe and parts of Asia while HEV-4 is enzootic in China and Korea and is emerging as the major cause of human hepatitis E in the region, outcompeting HEV1 in the last decade [39,40,41]. HEV-5 and HEV-6 are novel genotypes identified in Japanese wild boars [42,43] and cluster together with HEV-4 isolates on phylogenetic analysis (Figure 2). HEV-7 and HEV-8 were identified in camels [44,45]; their discovery and characteristics are detailed in the next section as an illustrative example of increasing recognition of Hepeviridae diversity.
Classification of the other Orthohepevirus species into genotypes has also been possible, but intra-species diversity is more limited compared to Orthohepevirus A requiring varying definitions of what constitutes a genotype. For example, the divergence among complete genome amino acid sequences of avian HEV (Orthohepevirus B) is less than 6%, which is even lower than intra-genotypic diversity in swine HEV-3 [27]. There is sufficient diversity between rodent and ferret HEV to classify Orthohepevirus C into two genotypes while there is insufficient sequence information at this stage to further classify bat HEV (Orthohepevirus D) [27].
For classification of individual HEV genotypes into subtypes, the initial work of Lu et al. [24] has been expanded further by analysis of nucleotide p-distances of all available complete HEV genome sequences and assignment of reference sequences for each subtype [46]. HEV-1 was identified to have six subtypes divisible into two clades, HEV-3 has ten subtypes after excluding the related rabbit HEV clade, and HEV-4 has nine subtypes [46]. Subtype assignment is complex as pairwise p-distance variation is often a continuum within and between subtypes; this again precludes setting any fixed demarcation definition of what constitutes a subtype. Several HEV variants still await definitive subtype assignment based on the extant framework. It may be noted that viral subtype has not been correlated with clinical severity or increased inter-species transmissibility [47]. Furthermore, the study of HEV epidemiology, transmission patterns and evolution rely more on identification of clades from sequence datasets rather than precise subtype designations of individual sequences [48,49]. However, the importance of a well curated and labeled database of HEV complete genome or subgenomic sequences as an aid to epidemiological research cannot be overemphasized.

5. Discovery of Camel HEV Genotypes

The recent discovery of two camelid HEV genotypes by our group is an illustrative example of our rapidly expanding understanding of HEV ecology [44,45]. In 2014, we reported the discovery of camelid HEV in dromedary camels (Camelus dromedarius or one-humped camels) from Dubai and then, in 2016, in Bactrian camels (Camelus bactrianus or two-humped camels) from Xinjiang, further expanding the mammalian host diversity of HEV. These camel HEV genomes possessed >20% nucleotide difference to all other HEVs with complete genome sequences available and, therefore, have been proposed as new genotypes of HEV (Table 1): HEV-7 for dromedary camel HEV (DcHEV) and HEV-8 for Bactrian camel HEV (BcHEV). A recent reported case of chronic HEV-7 infection in a liver transplant recipient who regularly consumed camel products [10] suggests the potential high impact to human health of novel genotypes within Orthohepevirus A.
Complete genome sequencing was performed on two DcHEV strains (DcHEV 178C and 180C) and three BcHEV strains (DcHEV 12XJ, 48XJ and 62XJ). The genome size of camel HEVs ranged from 7212 to 7223 bases, with G + C content of 52.7% to 55.1% (Table 2). The camel HEV genomes contained three major ORFs, with typical genome organization and characteristics similar to other HEV genotypes of Orthohepevirus A (Figure 1). ORF1 polyprotein contained domains consistent with a methyltransferase, a peptide containing a Y-domain, a papain-like cysteine protease, a peptide with a hypervariable region (HVR), a helicase, and an RNA-dependent RNA polymerase. Conserved sequences TLYTRTWS and RRLLXXYPDG that bound the HVR of HEV-1 to HEV-6 [42,50], but not in HEVs of other Orthohepevirus species, were also present in camel HEVs. A conserved motif (T/V)SGFSS(X)F(X)P immediately preceding the HVR of HEV-3 to HEV-6, but not present in HEV-1, HEV-2 or HEVs of other Orthohepevirus species, were also present in HEV-7 and HEV-8 as VSGFSSDFAP and TSGFSSNFSP respectively. The relative excess of proline and serine observed in the HVR of all other HEVs was also observed for camel HEVs. For DcHEV strain 178C (HEV-7), ORF2 began at nt 5172, similar to HEV-4 to HEV-6 with an insertion of a single nucleotide (U) at nt 5146, and ended at nt 7154, encoding a capsid protein of 660 aa (Table 2; Figure 3). As for DcHEV strain 180C (HEV-7) and the three BcHEV strains 12XJ, 48XJ and 62XJ (HEV-8), because of the lack of U insertion as in HEV-1, HEV-2 and HEV-3, ORF2 began at nt 5171 for DcHEV strain 180C and nt 5176 for the three BcHEV strains, also encoding a capsid protein of 660 aa. For DcHEV strain 178C (HEV-7), similar to HEV-4 to HEV-6, ORF3 began at nt 5161 and ended at nt 5502, encoding a small phosphoprotein of 113 aa with a multifunctional C-terminal region (Table 2; Figure 3). As for DcHEV strain 180C (HEV-7) and the three BcHEV strains (HEV-8), due to the lack of the U insertion as in HEV1, HEV2 and HEV3, ORF3 begain at nt 5160 for DcHEV strain 180C and nt 5165 for the three BcHEV strains (HEV-8) (Table 2; Figure 3). The conserved cis-reactive element (UGAAUAACAUGU) located upstream of ORF2 and ORF3 in the camel HEV strains might serve as promoter for the synthesis of the subgenomic mRNA for these two ORFs (Figure 3). Most interestingly, the presence of a U insertion downstream to AUG2 in DcHEV strain 178C resembled those of HEV-4 to HEV-6, leading to three possible start codons (AUG1, AUG2 or AUG4) for its ORF2 but one possible start codon for its ORF3 (AUG3), whereas the lack of this U insertion downstream to AUG2 in DcHEV strain 180C resembled those of HEV1, HEV2 and HEV3 and the three BcHEV strains (HEV-8), leading to only one possible start codon for its ORF2 (AUG4) but three possible start codons for its ORF3 (AUG1, AUG2 or AUG3) (Figure 3). The presence/absence of such a U insertion in different strains of the same HEV genotype has never been observed in other HEV genotypes and is so far unique to DcHEV (HEV-7).
Phylogenetic trees constructed using concatenated ORF1/ORF2 excluding the HVR (Figure 2), ORF1 (Figure 4), ORF2 (Figure 5), ORF3 (Figure 6) and showed that the three Bactrian camel HEV strains (HEV-8) were clustered with the two dromedary camel HEV strains (HEV-7) and the HEV-7 strain from the liver-transplant recipient with chronic hepatitis [10], and they were clustered with different HEVs in different phylogenetic trees. For ORF1 and concatenated ORF1/ORF2 excluding the HVR, HEV-7 and HEV-8 were clustered with HEV-3. However, they were clustered with HEV-1 and HEV-2 for ORF2 and clustered with HEV-2 for ORF3, but with low bootstrap support. Although different regions of the camel HEV genomes may be more similar to different genotypes of HEV, recombinational analysis performed using bootscan analysis revealed no obvious and definite site of recombination. Amino acid distances based on the concatenated ORF1/ORF2 excluding the HVR region of HEV-7 and HEV-8, and those of camel HEVs and the existing genotypes were ≥0.1, which was greater than the threshold (i.e., p-distance = 0.088) to demarcate inter-genotype distance [27] (Table 3), supporting that the camel HEVs should constitute two different HEV genotypes, for which HEV-7 and HEV-8 were proposed for DcHEV and BcHEV, respectively.

6. Delving into the Sequence: Recent Insights into HEV Molecular Epidemiology and Evolution

Rapidly accumulating sequence information over the last two decades has enabled new insights into the evolution of HEV and its adaptation to new hosts. Such studies have largely focused on HEV-1, HEV-3 and HEV-4 in view of the relative importance to human health of these HEV genotypes and abundance of publicly available sequence information. Questions addressed include the ancient origins of HEV, reasons for current genotypic distribution, host restriction, zoonotic transmission, local epidemiological trends, and potential future evolutionary trends of this family.
A recent systematic search for homologs of various HEV proteins in other viral families showed that the HEV1 RdRp protein sequence shares greater identity with insect viruses (Alphatetraviridae) and plant viruses (Benyviridae, Betaflexiviridae and Virgaviridae) compared to mammalian viruses [51]. However, phylogenetic analysis of the HEV ORF2 protein shows that it clusters together with members of the family Astroviridae and is quite distant from the aforementioned RdRp-homologous viral families; similarities in capsid crystal structure between astroviruses and HEV have also been noted lending credence to the theory of common ancestry [52,53]. Although convergent molecular evolution of genes encoding conserved enzymatic functions may theoretically be observed among unrelated viral families, this intriguing contrast in structural and non-structural protein phylogeny indicates a recombination event between the ORF1 sequence of insect/plant viruses and the ORF2 sequence of Astroviridae ancestors to produce a hybrid Hepeviridae ancestor.
Divergence analysis of HEV1–4 suggests that the split into zoonotic and anthropotropic genotypes occurred approximately 536 to 1344 years ago although significant underestimation due to the limitations of evolutionary models is possible [54]. HEV-1 appears to be more recent than the zoonotic genotypes with the estimated time to most recent common ancestor (TMRCA) of most modern lineages of HEV-1 being ~87–199 years ago [54]. Population dynamics of HEV-1, HEV-3 and HEV-4 over the last century have also been described linking fluctuations in effective population size to global trade, wars, fluctuations in pork consumption, increased recognition of hepatitis E as a zoonosis and control measures in swine [54,55].
Comparison of non-synonymous (dN) and synonymous (dS) substitutions in each codon position of HEV genotypes 1, 3 and 4 reveals that most of the HEV genome is under purifying selection (dN < dS) irrespective of genotype. Exceptions are the hypervariable region of ORF1 and the ORF2/ORF3 overlap region, which appear to be under positive selection, a trend that is especially prominent in the zoonotic genotypes HEV-3 and HEV-4 [54,56]. Evolutionary rates differ between genotypes within Orthohepevirus A; HEV-3 and HEV-4 appear to have higher substitution rates over time and fewer conserved sites than HEV-1 across the entire genome [56]. Furthermore, codon usage bias of HEV-3 and HEV-4 ORFs tends to be lower than HEV-1 [57]. It is postulated that these findings may reflect the need of zoonotic genotypes to adapt to multiple hosts and therefore different cell types with distinct microenvironments and codon usage preferences. However, such host-specific adaptations at the molecular level could not be demonstrated in experimentally infected pigs inoculated with a HEV-3f isolate derived from a human [58]. Studies have attempted to link observed HEV sequence variations to viral host-specificity markers and inter-species transmissibility, but functional confirmation of such in silico analyses is still pending [59,60].
Evolutionary dynamics of HEV on a short-term local scale have been studied to explain the pattern of locally predominant subtypes. Transregional flow of HEV-4 across provinces in China has been demonstrated by phylogenetic and coalescent-based inference [61]. Similarly, Nakano et al. were able to demonstrate the indigenization of European HEV-3e variants in Mie prefecture of Japan in both humans and wild boar [62,63] probably through importation of large-race pigs from Europe approximately fifty years ago. Similar analyses have been conducted for HEV strains sequenced in Europe [64,65].
Intra-host viral evolution has also been recognized in immunocompromised individuals with chronic hepatitis E infection. Analogous to other chronic viral infections [66,67,68], HEV in chronically infected patients exists in the form of a cloud of closely-related variants which may potentially exhibit quasispecies behavior. These variants likely arise due to fluctuating immunological pressures from the host; composition of viral population tends to stabilize over time without treatment [69]. Such viral heterogeneity may have direct clinical consequences; Kamar et al. reported neurological symptoms in a renal transplant recipient with chronic HEV infection and identified distinct potentially neurotropic quasispecies in the patient’s cerebrospinal fluid [70], while Lhomme and colleagues have reported that increased quasispecies heterogeneity in the polyproline and macro regions of ORF1 may potentially be linked to chronic infections in immunocompromised hosts [71,72]. Viral heterogeneity is also of importance in patients receiving ribavirin treatment. While ribavirin may have multiple mechanisms of action including direct antiviral effects, depletion of intracellular guanosine triphosphate pools and immunomodulatory mechanisms, the prevailing hypothesis is that it induces viral mutagenesis at a rate beyond the error threshold pushing the population into extinction [73,74]. There is clear evidence for increased viral heterogeneity in ribavirin treated patients assessed using next generation sequencing. While ribavirin is the only effective antiviral available for chronic HEV infection, some patients are observed to be treatment refractory. In such patients, viral variants with mutations in the HEV RdRp region are selected out (e.g., G1634R, K1383N, D1384G, and K1398R) during treatment; the significance of these mutations in determining the ribavirin resistant phenotype is uncertain due to the difficulty in conducting in vitro studies and lack of widely accessible animal models [69,75,76].
While considerable advances have been made in the last decade towards an understanding of the molecular evolution and epidemiology of HEV variants of clinical importance, further high-quality complete genome sequences of other genotypes within Orthohepevirus A (including wild boar and camelid HEV) will be required so that these genotypes may be included in analyses. This is of vital importance due to the recent description of chronic camelid HEV infection in an immunocompromised patient [10] and possible transmission of wild boar HEV genotypes to humans [35], which indicates that zoonotic HEV from non-swine sources may be an emerging underestimated cause of hepatitis in humans. Further intensive studies to elucidate inter-species transmission patterns of these novel genotypes are required.

7. Conclusions: Future Directions

Our understanding of the diversity of the family Hepeviridae is constantly evolving. With accumulating sequence information and discovery of novel genotypes, it is likely that taxonomic classifications will require constant revisions to keep pace with advances. Future directions may include targeted discovery programs looking for novel Orthohepevirus A genotypes in artiodactyls living in close proximity with humans. Recent advances in metagenomic approaches and next-generation sequencing could greatly streamline this process and may potentially identify novel sources and routes of transmission. From the clinical perspective, due to the high degree of capsid structure amino acid identity among different genotypes within Orthohepevirus A, increasing evidence for zoonotic transmission from non-swine sources will be expected to accumulate. In particular, the importance of camelid hepatitis E genotypes in causing human hepatitis in enzootic areas urgently requires further study. Furthermore, constant vigilance for novel recombinants will be required. The ever-increasing cache of genomic data and sophisticated models will be useful to address questions related to HEV evolution and epidemiology; a preponderance of the extant data originates from Europe and East Asia, extending their approaches to other parts of the world will enable us to capture a global perspective and identify previously missed links. Finally, a better understanding of intra-host evolution of HEV during human infection may enable us to predict clinical outcomes and treatment response in patients at risk of chronic and fulminant HEV infection.

Author Contributions

Siddharth Sridhar wrote the manuscript; Jade L. L. Teng prepared the figures and wrote the section on camelid HEV; Tsz-Ho Chiu prepared the tables; and Susanna K. P. Lau and Patrick C. Y. Woo conceived the format of the manuscript and edited it.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. WHO. Hepatitis E Fact Sheet. Available online: http://www.who.int/mediacentre/factsheets/fs280/en/ (accessed on 15 February 2017).
  2. Ren, X.; Wu, P.; Wang, L.; Geng, M.; Zeng, L.; Zhang, J.; Xia, N.; Lai, S.; Dalton, H.R.; Cowling, B.J.; et al. Changing epidemiology of hepatitis A and hepatitis E viruses in China, 1990–2014. Emerg. Infect. Dis. 2017, 23, 276–279. [Google Scholar] [CrossRef] [PubMed]
  3. Jin, H.; Zhao, Y.; Zhang, X.; Wang, B.; Liu, P. Case-fatality risk of pregnant women with acute viral hepatitis type E: A systematic review and meta-analysis. Epidemiol. Infect. 2016, 144, 2098–2106. [Google Scholar] [CrossRef] [PubMed]
  4. Kamar, N.; Selves, J.; Mansuy, J.M.; Ouezzani, L.; Peron, J.M.; Guitard, J.; Cointault, O.; Esposito, L.; Abravanel, F.; Danjoux, M.; et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 2008, 358, 811–817. [Google Scholar] [CrossRef] [PubMed]
  5. Giordani, M.T.; Fabris, P.; Brunetti, E.; Goblirsch, S.; Romano, L. Hepatitis E and lymphocytic leukemia in Man, Italy. Emerg. Infect. Dis. 2013, 19, 2054–2056. [Google Scholar] [CrossRef] [PubMed]
  6. Neukam, K.; Barreiro, P.; Macias, J.; Avellon, A.; Cifuentes, C.; Martin-Carbonero, L.; Echevarria, J.M.; Vargas, J.; Soriano, V.; Pineda, J.A. Chronic hepatitis E in HIV patients: Rapid progression to cirrhosis and response to oral ribavirin. Clin. Infect. Dis. 2013, 57, 465–468. [Google Scholar] [CrossRef] [PubMed]
  7. WHO. The Global Prevalence of Hepatitis E Viral Prevalence and Susceptibility: A Systematic Review. Available online: http://apps.who.int/iris/bitstream/10665/70513/1/WHO_IVB_10.14_eng.pdf?ua=1 (accessed on 15 February 2017).
  8. Sridhar, S.; Lau, S.K.; Woo, P.C. Hepatitis E: A disease of reemerging importance. J. Formos. Med. Assoc. 2015, 114, 681–690. [Google Scholar] [CrossRef] [PubMed]
  9. Tei, S.; Kitajima, N.; Takahashi, K.; Mishiro, S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003, 362, 371–373. [Google Scholar] [CrossRef]
  10. Lee, G.H.; Tan, B.H.; Teo, E.C.; Lim, S.G.; Dan, Y.Y.; Wee, A.; Aw, P.P.; Zhu, Y.; Hibberd, M.L.; Tan, C.K.; et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology 2016, 150, 355–357. [Google Scholar] [CrossRef] [PubMed]
  11. Kim, Y.M.; Jeong, S.H.; Kim, J.Y.; Song, J.C.; Lee, J.H.; Kim, J.W.; Yun, H.; Kim, J.S. The first case of genotype 4 hepatitis E related to wild boar in South Korea. J. Clin. Virol. 2011, 50, 253–256. [Google Scholar] [CrossRef] [PubMed]
  12. Li, T.C.; Chijiwa, K.; Sera, N.; Ishibashi, T.; Etoh, Y.; Shinohara, Y.; Kurata, Y.; Ishida, M.; Sakamoto, S.; Takeda, N.; et al. Hepatitis E virus transmission from wild boar meat. Emerg. Infect. Dis. 2005, 11, 1958–1960. [Google Scholar] [CrossRef] [PubMed]
  13. Izopet, J.; Dubois, M.; Bertagnoli, S.; Lhomme, S.; Marchandeau, S.; Boucher, S.; Kamar, N.; Abravanel, F.; Guerin, J.L. Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Emerg. Infect. Dis. 2012, 18, 1274–1281. [Google Scholar] [CrossRef] [PubMed]
  14. Debing, Y.; Moradpour, D.; Neyts, J.; Gouttenoire, J. Update on hepatitis E virology: Implications for clinical practice. J. Hepatol. 2016, 65, 200–212. [Google Scholar] [CrossRef] [PubMed]
  15. Graff, J.; Torian, U.; Nguyen, H.; Emerson, S.U. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J. Virol. 2006, 80, 5919–5926. [Google Scholar] [CrossRef] [PubMed]
  16. Koonin, E.V.; Gorbalenya, A.E.; Purdy, M.A.; Rozanov, M.N.; Reyes, G.R.; Bradley, D.W. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: Delineation of an additional group of positive-strand RNA plant and animal viruses. Proc. Natl. Acad. Sci. USA 1992, 89, 8259–8263. [Google Scholar] [CrossRef] [PubMed]
  17. Panda, S.K.; Varma, S.P. Hepatitis E: Molecular virology and pathogenesis. J. Clin. Exp. Hepatol. 2013, 3, 114–124. [Google Scholar] [CrossRef] [PubMed]
  18. Kannan, H.; Fan, S.; Patel, D.; Bossis, I.; Zhang, Y.J. The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics. J. Virol. 2009, 83, 6375–6382. [Google Scholar] [CrossRef] [PubMed]
  19. Nagashima, S.; Takahashi, M.; Jirintai, S.; Tanggis; Kobayashi, T.; Nishizawa, T.; Okamoto, H. The membrane on the surface of hepatitis E virus particles is derived from the intracellular membrane and contains trans-golgi network protein 2. Arch. Virol. 2014, 159, 979–991. [Google Scholar] [CrossRef] [PubMed]
  20. Yang, T.; Kataoka, M.; Ami, Y.; Suzaki, Y.; Kishida, N.; Shirakura, M.; Imai, M.; Asanuma, H.; Takeda, N.; Wakita, T.; et al. Characterization of self-assembled virus-like particles of ferret hepatitis E virus generated by recombinant Baculoviruses. J. Gen. Virol. 2013, 94, 2647–2656. [Google Scholar] [CrossRef] [PubMed]
  21. Zhou, X.; Kataoka, M.; Liu, Z.; Takeda, N.; Wakita, T.; Li, T.C. Characterization of self-assembled virus-like particles of dromedary camel hepatitis E virus generated by recombinant Baculoviruses. Virus. Res. 2015, 210, 8–17. [Google Scholar] [CrossRef] [PubMed]
  22. Wang, S.; Cheng, X.; Dai, X.; Dong, C.; Xu, M.; Liang, J.; Dong, M.; Purdy, M.A.; Meng, J. Rabbit and human hepatitis E virus strains belong to a single serotype. Virus Res. 2013, 176, 101–106. [Google Scholar] [CrossRef] [PubMed]
  23. Wang, S.; Dong, C.; Dai, X.; Cheng, X.; Liang, J.; Dong, M.; Purdy, M.A.; Meng, J. Hepatitis E virus isolated from rabbits is genetically heterogeneous but with very similar antigenicity to human HEV. J. Med. Virol. 2013, 85, 627–635. [Google Scholar] [CrossRef] [PubMed]
  24. Lu, L.; Li, C.; Hagedorn, C.H. Phylogenetic analysis of global hepatitis E virus sequences: Genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 2006, 16, 5–36. [Google Scholar] [CrossRef] [PubMed]
  25. Schlauder, G.G.; Desai, S.M.; Zanetti, A.R.; Tassopoulos, N.C.; Mushahwar, I.K. Novel hepatitis E virus (HEV) isolates from europe: Evidence for additional genotypes of HEV. J. Med. Virol. 1999, 57, 243–251. [Google Scholar] [CrossRef]
  26. Schlauder, G.G.; Mushahwar, I.K. Genetic heterogeneity of hepatitis E virus. J. Med. Virol. 2001, 65, 282–292. [Google Scholar] [CrossRef] [PubMed]
  27. Smith, D.B.; Simmonds, P.; International Committee on Taxonomy of Viruses Hepeviridae Study Group; Jameel, S.; Emerson, S.U.; Harrison, T.J.; Meng, X.J.; Okamoto, H.; Van der Poel, W.H.; Purdy, M.A. Consensus proposals for classification of the family Hepeviridae. J. Gen. Virol. 2014, 95, 2223–2232. [Google Scholar] [CrossRef] [PubMed]
  28. Smith, D.B.; Purdy, M.A.; Simmonds, P. Genetic variability and the classification of hepatitis E virus. J. Virol. 2013, 87, 4161–4169. [Google Scholar] [CrossRef] [PubMed]
  29. Worm, H.C.; van der Poel, W.H.; Brandstatter, G. Hepatitis E: An overview. Microbes Infect. 2002, 4, 657–666. [Google Scholar] [CrossRef]
  30. Gouvea, V.; Hoke, C.H., Jr.; Innis, B.L. Genotyping of hepatitis E virus in clinical specimens by restriction endonuclease analysis. J. Virol. Methods 1998, 70, 71–78. [Google Scholar] [CrossRef]
  31. Fan, J. Open reading frame structure analysis as a novel genotyping tool for hepatitis E virus and the subsequent discovery of an inter-genotype recombinant. J. Gen. Virol. 2009, 90, 1353–1358. [Google Scholar] [CrossRef] [PubMed]
  32. ICTV. Virus Taxonomy: 2015 Release. Available online: https://talk.ictvonline.org/taxonomy/ (accessed on 17 February 2017).
  33. Batts, W.; Yun, S.; Hedrick, R.; Winton, J. A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus. Res. 2011, 158, 116–123. [Google Scholar] [CrossRef] [PubMed]
  34. Chen, X.; Zhang, Q.; He, C.; Zhang, L.; Li, J.; Zhang, W.; Cao, W.; Lv, Y.G.; Liu, Z.; Zhang, J.X.; et al. Recombination and natural selection in hepatitis E virus genotypes. J. Med. Virol. 2012, 84, 1396–1407. [Google Scholar] [CrossRef] [PubMed]
  35. Meng, X.J. Expanding host range and cross-species infection of hepatitis E virus. PLoS Pathog. 2016, 12, e1005695. [Google Scholar] [CrossRef] [PubMed]
  36. Fierro, N.A.; Realpe, M.; Meraz-Medina, T.; Roman, S.; Panduro, A. Hepatitis E virus: An ancient hidden enemy in Latin America. World J. Gastroenterol. 2016, 22, 2271–2283. [Google Scholar] [PubMed]
  37. Huang, C.C.; Nguyen, D.; Fernandez, J.; Yun, K.Y.; Fry, K.E.; Bradley, D.W.; Tam, A.W.; Reyes, G.R. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology 1992, 191, 550–558. [Google Scholar] [CrossRef]
  38. Pavio, N.; Meng, X.J.; Doceul, V. Zoonotic origin of hepatitis E. Curr. Opin. Virol. 2015, 10, 34–41. [Google Scholar] [CrossRef] [PubMed]
  39. Jeong, S.H.; Park, B.J.; Kim, Y.H.; Choi, Y.S.; Ahn, H.S.; Han, S.H.; Choi, I.S. Isolation of hepatitis E virus genotype 4 from patients with acute cryptogenic hepatitis in Korea. J. Clin. Virol. 2017, 89, 10–13. [Google Scholar] [CrossRef] [PubMed]
  40. Wang, L.; Geng, J. Acute hepatitis E virus infection in patients with acute liver failure in China: Not quite an uncommon cause. Hepatology 2016. [Google Scholar] [CrossRef] [PubMed]
  41. Wang, L.; Liu, L.; Wei, Y.; Wang, Q.; Tian, Q.; Wang, L.; Zhuang, H. Clinical and virological profiling of sporadic hepatitis E virus infection in China. J. Infect. 2016, 73, 271–279. [Google Scholar] [CrossRef] [PubMed]
  42. Takahashi, M.; Nishizawa, T.; Sato, H.; Sato, Y.; Jirintai; Nagashima, S.; Okamoto, H. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J. Gen. Virol. 2011, 92, 902–908. [Google Scholar] [CrossRef] [PubMed]
  43. Sato, Y.; Sato, H.; Naka, K.; Furuya, S.; Tsukiji, H.; Kitagawa, K.; Sonoda, Y.; Usui, T.; Sakamoto, H.; Yoshino, S.; et al. A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: Identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes. Arch. Virol. 2011, 156, 1345–1358. [Google Scholar] [CrossRef] [PubMed]
  44. Woo, P.C.; Lau, S.K.; Teng, J.L.; Cao, K.Y.; Wernery, U.; Schountz, T.; Chiu, T.H.; Tsang, A.K.; Wong, P.C.; Wong, E.Y.; et al. New hepatitis E virus genotype in Bactrian camels, Xinjiang, China, 2013. Emerg. Infect. Dis. 2016, 22, 2219–2221. [Google Scholar] [CrossRef] [PubMed]
  45. Woo, P.C.; Lau, S.K.; Teng, J.L.; Tsang, A.K.; Joseph, M.; Wong, E.Y.; Tang, Y.; Sivakumar, S.; Xie, J.; Bai, R.; et al. New hepatitis E virus genotype in camels, the Middle East. Emerg. Infect. Dis. 2014, 20, 1044–1048. [Google Scholar] [CrossRef] [PubMed]
  46. Smith, D.B.; Simmonds, P.; Izopet, J.; Oliveira-Filho, E.F.; Ulrich, R.G.; Johne, R.; Koenig, M.; Jameel, S.; Harrison, T.J.; Meng, X.J.; et al. Proposed reference sequences for hepatitis E virus subtypes. J. Gen. Virol. 2016, 97, 537–542. [Google Scholar] [CrossRef] [PubMed]
  47. Smith, D.B.; Ijaz, S.; Tedder, R.S.; Hogema, B.; Zaaijer, H.L.; Izopet, J.; Bradley-Stewart, A.; Gunson, R.; Harvala, H.; Kokki, I.; et al. Variability and pathogenicity of hepatitis E virus genotype 3 variants. J. Gen. Virol. 2015, 96, 3255–3264. [Google Scholar] [CrossRef] [PubMed]
  48. Ijaz, S.; Said, B.; Boxall, E.; Smit, E.; Morgan, D.; Tedder, R.S. Indigenous hepatitis E in England and Wales from 2003 to 2012: Evidence of an emerging novel phylotype of viruses. J. Infect. Dis. 2014, 209, 1212–1218. [Google Scholar] [CrossRef] [PubMed]
  49. Oliveira-Filho, E.F.; Konig, M.; Thiel, H.J. Genetic variability of HEV isolates: Inconsistencies of current classification. Vet. Microbiol. 2013, 165, 148–154. [Google Scholar] [CrossRef] [PubMed]
  50. Purdy, M.A.; Lara, J.; Khudyakov, Y.E. The hepatitis E virus polyproline region is involved in viral adaptation. PLoS ONE 2012, 7, e35974. [Google Scholar] [CrossRef] [PubMed]
  51. Kelly, A.G.; Netzler, N.E.; White, P.A. Ancient recombination events and the origins of hepatitis E virus. BMC Evol. Biol. 2016, 16, 210. [Google Scholar] [CrossRef] [PubMed]
  52. Dryden, K.A.; Tihova, M.; Nowotny, N.; Matsui, S.M.; Mendez, E.; Yeager, M. Immature and mature human astrovirus: Structure, conformational changes, and similarities to hepatitis E virus. J. Mol. Biol. 2012, 422, 650–658. [Google Scholar] [CrossRef] [PubMed]
  53. Toh, Y.; Harper, J.; Dryden, K.A.; Yeager, M.; Arias, C.F.; Mendez, E.; Tao, Y.J. Crystal structure of the human astrovirus capsid protein. J. Virol. 2016, 90, 9008–9017. [Google Scholar] [CrossRef] [PubMed]
  54. Purdy, M.A.; Khudyakov, Y.E. Evolutionary history and population dynamics of hepatitis E virus. PLoS ONE 2010, 5, e14376. [Google Scholar] [CrossRef] [PubMed]
  55. Mirazo, S.; Mir, D.; Bello, G.; Ramos, N.; Musto, H.; Arbiza, J. New insights into the hepatitis E virus genotype 3 phylodynamics and evolutionary history. Infect. Genet. Evol. 2016, 43, 267–273. [Google Scholar] [CrossRef] [PubMed]
  56. Brayne, A.B.; Dearlove, B.L.; Lester, J.S.; Kosakovsky Pond, S.L.; Frost, S.D. Genotype-specific evolution of hepatitis E virus. J. Virol. 2017. [Google Scholar] [CrossRef] [PubMed]
  57. Bouquet, J.; Cherel, P.; Pavio, N. Genetic characterization and codon usage bias of full-length hepatitis E virus sequences shed new lights on genotypic distribution, host restriction and genome evolution. Infect. Genet. Evol. 2012, 12, 1842–1853. [Google Scholar] [CrossRef] [PubMed]
  58. Bouquet, J.; Cheval, J.; Rogee, S.; Pavio, N.; Eloit, M. Identical consensus sequence and conserved genomic polymorphism of hepatitis E virus during controlled interspecies transmission. J. Virol. 2012, 86, 6238–6245. [Google Scholar] [CrossRef] [PubMed]
  59. Fu, H.; Wang, L.; Zhu, Y.; Geng, J.; Li, L.; Wang, X.; Bu, Q.; Zhuang, H. Analysing complete genome sequence of swine hepatitis E virus (HEV), strain chn-xj-sw13 isolated from Xinjiang, China: Putative host range, and disease severity determinants in HEV. Infect. Genet. Evol. 2011, 11, 618–623. [Google Scholar] [CrossRef] [PubMed]
  60. Geng, J.; Fu, H.; Wang, L.; Bu, Q.; Liu, P.; Wang, M.; Sui, Y.; Wang, X.; Zhu, Y.; Zhuang, H. Phylogenetic analysis of the full genome of rabbit hepatitis E virus (RBHEV) and molecular biologic study on the possibility of cross species transmission of RBHEV. Infect. Genet. Evol. 2011, 11, 2020–2025. [Google Scholar] [CrossRef] [PubMed]
  61. Yang, D.; Jiang, M.; Jin, M.; Qiu, Z.G.; Shen, Z.Q.; Cui, W.H.; Wang, D.N.; Gong, L.F.; Li, B.; Wang, X.W.; et al. Seroprevalence and evolutionary dynamics of genotype 4 hepatitis E virus in Shandong province, China. World J. Gastroenterol. 2014, 20, 7955–7963. [Google Scholar] [CrossRef] [PubMed]
  62. Nakano, T.; Okano, H.; Kobayashi, M.; Ito, K.; Ohmori, S.; Nomura, T.; Kato, H.; Ayada, M.; Nakano, Y.; Akachi, S.; et al. Molecular epidemiology and genetic history of European-type genotype 3 hepatitis E virus indigenized in the central region of Japan. Infect. Genet. Evol. 2012, 12, 1524–1534. [Google Scholar] [CrossRef] [PubMed]
  63. Nakano, T.; Takahashi, K.; Arai, M.; Okano, H.; Kato, H.; Ayada, M.; Okamoto, H.; Mishiro, S. Identification of European-type hepatitis E virus subtype 3e isolates in Japanese wild boars: Molecular tracing of HEV from swine to wild boars. Infect. Genet. Evol. 2013, 18, 287–298. [Google Scholar] [CrossRef] [PubMed]
  64. Lhomme, S.; Abravanel, F.; Dubois, M.; Chapuy-Regaud, S.; Sandres-Saune, K.; Mansuy, J.M.; Rostaing, L.; Kamar, N.; Izopet, J. Temporal evolution of the distribution of hepatitis E virus genotypes in southwestern France. Infect. Genet. Evol. 2015, 35, 50–55. [Google Scholar] [CrossRef] [PubMed]
  65. Montesano, C.; Giovanetti, M.; Ciotti, M.; Cella, E.; Lo Presti, A.; Grifoni, A.; Zehender, G.; Angeletti, S.; Ciccozzi, M. Hepatitis E virus circulation in Italy: Phylogenetic and evolutionary analysis. Hepat. Mon. 2016, 16, e31951. [Google Scholar] [CrossRef] [PubMed]
  66. Schorn, R.; Hohne, M.; Meerbach, A.; Bossart, W.; Wuthrich, R.P.; Schreier, E.; Muller, N.J.; Fehr, T. Chronic norovirus infection after kidney transplantation: Molecular evidence for immune-driven viral evolution. Clin. Infect. Dis. 2010, 51, 307–314. [Google Scholar] [CrossRef] [PubMed]
  67. Carlsson, B.; Lindberg, A.M.; Rodriguez-Diaz, J.; Hedlund, K.O.; Persson, B.; Svensson, L. Quasispecies dynamics and molecular evolution of human norovirus capsid P region during chronic infection. J. Gen. Virol. 2009, 90, 432–441. [Google Scholar] [CrossRef] [PubMed]
  68. Domingo, E.; Sheldon, J.; Perales, C. Viral quasispecies evolution. Microbiol. Mol. Biol. Rev. 2012, 76, 159–216. [Google Scholar] [CrossRef] [PubMed]
  69. Todt, D.; Gisa, A.; Radonic, A.; Nitsche, A.; Behrendt, P.; Suneetha, P.V.; Pischke, S.; Bremer, B.; Brown, R.J.; Manns, M.P.; et al. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut 2016, 65, 1733–1743. [Google Scholar] [CrossRef] [PubMed]
  70. Kamar, N.; Izopet, J.; Cintas, P.; Garrouste, C.; Uro-Coste, E.; Cointault, O.; Rostaing, L. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am. J. Transplant. 2010, 10, 1321–1324. [Google Scholar] [CrossRef] [PubMed]
  71. Lhomme, S.; Garrouste, C.; Kamar, N.; Saune, K.; Abravanel, F.; Mansuy, J.M.; Dubois, M.; Rostaing, L.; Izopet, J. Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients. J. Infect. Dis. 2014, 209, 300–303. [Google Scholar] [CrossRef] [PubMed]
  72. Lhomme, S.; Abravanel, F.; Dubois, M.; Sandres-Saune, K.; Rostaing, L.; Kamar, N.; Izopet, J. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J. Virol. 2012, 86, 10006–10014. [Google Scholar] [CrossRef] [PubMed]
  73. Todt, D.; Walter, S.; Brown, R.J.; Steinmann, E. Mutagenic effects of ribavirin on hepatitis E virus-viral extinction versus selection of fitness-enhancing mutations. Viruses 2016. [Google Scholar] [CrossRef] [PubMed]
  74. Debing, Y.; Emerson, S.U.; Wang, Y.; Pan, Q.; Balzarini, J.; Dallmeier, K.; Neyts, J. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob. Agents Chemother. 2014, 58, 267–273. [Google Scholar] [CrossRef] [PubMed]
  75. Debing, Y.; Ramiere, C.; Dallmeier, K.; Piorkowski, G.; Trabaud, M.A.; Lebosse, F.; Scholtes, C.; Roche, M.; Legras-Lachuer, C.; de Lamballerie, X.; et al. Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity. J. Hepatol. 2016, 65, 499–508. [Google Scholar] [CrossRef] [PubMed]
  76. Debing, Y.; Gisa, A.; Dallmeier, K.; Pischke, S.; Bremer, B.; Manns, M.; Wedemeyer, H.; Suneetha, P.V.; Neyts, J. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology 2014, 147, 1008–1011. [Google Scholar] [CrossRef] [PubMed]
Ijms 18 00869 g001 550
Figure 1. Predicted genomic organization of HEV-1 to HEV-8, considering the reading frame of ORF1 as frame 1. Reading frames of ORF2 and ORF3 are labeled relative to ORF1 reading frame. HEV-1 (M73218); HEV-2 (M74506); HEV-3 (AP003430); HEV-4 (AJ272108); HEV-5 (AB573435); HEV-6 (AB602441); HEV-7 strain DcHEV-178C (KJ496143); HEV-7 strain DcHEV-180C (KJ496144), HEV-8 (KX387865).
Figure 1. Predicted genomic organization of HEV-1 to HEV-8, considering the reading frame of ORF1 as frame 1. Reading frames of ORF2 and ORF3 are labeled relative to ORF1 reading frame. HEV-1 (M73218); HEV-2 (M74506); HEV-3 (AP003430); HEV-4 (AJ272108); HEV-5 (AB573435); HEV-6 (AB602441); HEV-7 strain DcHEV-178C (KJ496143); HEV-7 strain DcHEV-180C (KJ496144), HEV-8 (KX387865).
Ijms 18 00869 g001
Ijms 18 00869 g002 550
Figure 2. Phylogenetic analyses of ORF1/ORF2 proteins excluding the hypervariable region (HVR) of HEVs within the genus Orthohepevirus (Species A to D). The tree was constructed using maximum likelihood method and the optimal substitution model of JTT + G + I was used. In total, 2282 acid positions (amino acid residues 1–706 and 789–2409, numbered with reference to GenBank sequence M73218) were included in the analyses. The scale bar indicates the estimated number of substitutions per 20 amino acids. GenBank accession numbers are shown in brackets.
Figure 2. Phylogenetic analyses of ORF1/ORF2 proteins excluding the hypervariable region (HVR) of HEVs within the genus Orthohepevirus (Species A to D). The tree was constructed using maximum likelihood method and the optimal substitution model of JTT + G + I was used. In total, 2282 acid positions (amino acid residues 1–706 and 789–2409, numbered with reference to GenBank sequence M73218) were included in the analyses. The scale bar indicates the estimated number of substitutions per 20 amino acids. GenBank accession numbers are shown in brackets.
Ijms 18 00869 g002
Ijms 18 00869 g003 550
Figure 3. Alignment of nucleotide sequences showing potential start codons for ORF2 and ORF3 in HEV-1 to HEV-8. Potential start codons of ORF3 are shaded by red boxes, and those of ORF2 by blue boxes. The inserted U residues are indicated by open box. The stop codon of ORF1 is marked with asterisks. The conserved cis-reactive element with the sequence UGAAUAACAUGU is underlined, which might serve as promoter for the synthesis of the subgenomic mRNA for the ORF2 and ORF3.
Figure 3. Alignment of nucleotide sequences showing potential start codons for ORF2 and ORF3 in HEV-1 to HEV-8. Potential start codons of ORF3 are shaded by red boxes, and those of ORF2 by blue boxes. The inserted U residues are indicated by open box. The stop codon of ORF1 is marked with asterisks. The conserved cis-reactive element with the sequence UGAAUAACAUGU is underlined, which might serve as promoter for the synthesis of the subgenomic mRNA for the ORF2 and ORF3.
Ijms 18 00869 g003
Ijms 18 00869 g004 550
Figure 4. Phylogenetic analyses of ORF1of HEVs within the genus Orthohepevirus (Species A to D). The tree was constructed using maximum likelihood method and the optimal substitution model of JTT + G + I + F was used. Amino acid residues 1–1743 in ORF1, numbered with reference to GenBank sequence M73218, were included in the analyses. The scale bar indicates the estimated number of substitutions per 20 amino acids. GenBank accession numbers are shown in brackets.
Figure 4. Phylogenetic analyses of ORF1of HEVs within the genus Orthohepevirus (Species A to D). The tree was constructed using maximum likelihood method and the optimal substitution model of JTT + G + I + F was used. Amino acid residues 1–1743 in ORF1, numbered with reference to GenBank sequence M73218, were included in the analyses. The scale bar indicates the estimated number of substitutions per 20 amino acids. GenBank accession numbers are shown in brackets.
Ijms 18 00869 g004
Ijms 18 00869 g005 550
Figure 5. Phylogenetic analyses of ORF2 of HEVs within the genus Orthohepevirus (Species A to D). The tree was constructed using maximum likelihood method and the optimal substitution model of JTT + G + I was used. Amino acid residues 1–660 in ORF2, numbered with reference to GenBank sequence M73218, were included in the analyses. The scale bar indicates the estimated number of substitutions per 50 amino acids. GenBank accession numbers are shown in brackets.
Figure 5. Phylogenetic analyses of ORF2 of HEVs within the genus Orthohepevirus (Species A to D). The tree was constructed using maximum likelihood method and the optimal substitution model of JTT + G + I was used. Amino acid residues 1–660 in ORF2, numbered with reference to GenBank sequence M73218, were included in the analyses. The scale bar indicates the estimated number of substitutions per 50 amino acids. GenBank accession numbers are shown in brackets.
Ijms 18 00869 g005
Ijms 18 00869 g006 550
Figure 6. Phylogenetic analyses of ORF3 of HEVs within the genus Orthohepevirus (Species A to D). The tree was constructed using maximum likelihood method and the optimal substitution model of JTT + G was used. Amino acid residues 10–123 in ORF3, numbered with reference to GenBank sequence M73218, were included in the analyses. The scale bar indicates the estimated number of substitutions per 20 amino acids. GenBank accession numbers are shown in brackets.
Figure 6. Phylogenetic analyses of ORF3 of HEVs within the genus Orthohepevirus (Species A to D). The tree was constructed using maximum likelihood method and the optimal substitution model of JTT + G was used. Amino acid residues 10–123 in ORF3, numbered with reference to GenBank sequence M73218, were included in the analyses. The scale bar indicates the estimated number of substitutions per 20 amino acids. GenBank accession numbers are shown in brackets.
Ijms 18 00869 g006
Table
Table 1. Comparison of nucleotide and deduced amino acid sequence identities of the most recently discovered genotype, HEV-8 (BcHEV-48XJ), and other genotypes of HEV *.
Table 1. Comparison of nucleotide and deduced amino acid sequence identities of the most recently discovered genotype, HEV-8 (BcHEV-48XJ), and other genotypes of HEV *.
HEV Genotypes/Strains (GenBank Accession No.)HEV-8 Strain BcHEV-48XJ (KX387866)
Nucleotide Identity (%)Amino Acid Identity (%)
Entire GenomeORF1ORF2ORF3ORF1ORF2ORF3
Orthohepevirus A
HEV-1
 Human HEV subtype 1a (M73218)73.771.976.984.481.289.874.0
 Human HEV subtype 1b (D11092)73.871.877.284.181.190.074.0
 Human HEV subtype 1b (L08816)73.471.876.984.181.289.773.2
 Human HEV subtype 1c (X98292)73.771.677.484.181.589.575.6
 Human HEV subtype 1d (AY230202)74.372.178.484.781.690.274.0
 Human HEV subtype 1e (AY204877) †73.471.677.684.479.890.274.0
 Human HEV subtype 1f (JF443721)73.871.777.879.981.090.380.7
HEV-2
 Human HEV subtype 2a (M74506) †73.27276.184.180.488.374.0
HEV-3
 Mongoose HEV subtype 3a (AB591734)75.874.278.585.985.793.071.3
 Swine HEV subtype 3a (AF082843)74.873.677.884.085.592.170.5
 Wild deer HEV subtype 3b (AB189071)75.373.978.584.885.692.671.3
 Human HEV subtype 3b (AP003430)75.373.678.385.685.992.973.0
 Wild boar HEV subtype 3c (FJ705359)75.87478.885.486.492.672.1
 Swine HEV subtype 3e (AB248521)75.473.778.485.986.092.474.6
Human HEV subtype 3f (AB369687)75.37478.285.985.992.973.8
 Human HEV subtype 3f (FJ653660)75.57478.285.485.992.473.8
 Swine HEV subtype 3g (AF455784)75.774.378.186.285.692.973.8
 Human HEV subtype 3h (JQ013794) †74.673.178.179.185.392.678.8
 Wild boar HEV subtype 3i (FJ998008) †75.173.978.084.086.092.970.5
 Swine HEV subtype 3j (AY115488)75.473.878.384.685.292.770.5
 Rabbit HEV subtype 3ra (FJ906895)74.171.778.482.482.288.670.5
HEV-4
 Human HEV subtype 4a (AB197673)74.772.779.579.783.591.175.4
 Swine HEV subtype 4b (DQ279091)74.872.480.480.283.490.774.6
 Human HEV subtype 4c (AB074915)75.473.381.179.783.690.575.4
 Human HEV subtype 4d (AJ272108)7573.279.377.583.688.970.2
 Swine HEV subtype 4e (AY723745)75.873.780.781.383.491.474.6
 Human HEV subtype 4f (AB220974)75.273.180.381.883.490.777.2
 Human HEV subtype 4g (AB108537)75.373.581.381.384.290.876.3
 Swine HEV subtype 4h (GU119961)75.273.179.979.982.790.176.3
 Swine HEV subtype 4i (DQ450072)75.573.280.087.082.792.473.0
HEV-5
 Wild boar HEV subtype 5a (AB573435)74.472.479.475.382.187.872.6
HEV-6
 Wild boar HEV 6 (AB856243)74.172.178.177.882.090.375.2
 Wild boar HEV subtype 6a (AB602441)74.573.276.577.581.389.873.7
HEV-7
 DcHEV 7 (KJ496144)75.97479.181.385.991.483.2
 Human HEV 7 (KT818608) †73.474.569.2NA85.982.1NA
 DcHEV subtype 7a (KJ496143)75.673.878.881.085.591.284.1
HEV-8
 BcHEV-62XJ (KX387867)98.398.298.899.798.899.7100.0
 BcHEV-12XJ (KX387865)96.396.197.097.898.099.299.1
Orthohepevirus B
Avian HEV genotype 2 (AY535004)52.952.851.642.343.244.824.8
Orthohepevirus C
Germany rat HEV (GU345042)57.15659.954.249.855.127.4
Vietnam rat HEV (JX120573)56.355.258.951.650.055.529.6
Ferret HEV (JN998606)56.254.760.549.550.555.926.5
Orthohepevirus D
Germany bat HEV (JQ001749)53.55354.847.043.747.322.9
Piscihepevirus A
Cutthroat trout HEV (HQ731075)48.148.547.937.428.420.215.5
* HEV, hepatitis E virus; BcHEV, HEV from Bactrian camel; DcHEV, HEV from dromedary camel; NA, not available because of incomplete genome. † Near-complete genome.
Table
Table 2. Comparison of genomic organization of HEV genotypes and isolates *.
Table 2. Comparison of genomic organization of HEV genotypes and isolates *.
HEV Genotypes/Strains (GenBank Accession No.)Genome Length, nt GC Content, %5′ UTR, ntORF1, aaORF2, aaORF3, aa3′ UTR, nt
Orthohepevirus A
HEV-1
 Human HEV1a (M73218) 719458.127169366011465
 Human HEV1b (D11092)719457.727169366012366
 Human HEV1c (X98292)719357.626169366012365
 Human HEV1d (AY230202)719257.425169366012365
 Human HEV1e (AY204877) §≥715357.4NA≥168866012365
 Human HEV1f (JF443721)719457.727169366011465
HEV-2
 Human HEV2a (M74506) ‡≥717056.5NA169165911474
HEV-3
 Human HEV3a (AB089824) 724455.325170966011372
 Swine HEV3a (AF082843)720755.69170866012254
 Human HEV3b (AP003430)723055.326170366012272
 Wild boar HEV3c (FJ705359)722255.525170366012268
 Swine HEV3e (AB248521)722554.725170466012268
 Human HEV3f (AB369687)721455.55170466012277
 Swine HEV3g (AF455784)721555.928169766012276
 Human HEV3h (JQ013794) §≥716356.0NA≥169166011368
 Wild boar HEV3i (FJ998008)≥719755.6NA170366012268
 Swine HEV3j (AY115488)724255.426170866012272
 Rabbit HEV3ra (FJ906895) ‡728355.526172266012271
HEV-4
 Human HEV4a (AB197673)723754.226170667411469
 Swine HEV4b (DQ279091)723454.726170567411469
 Human HEV4c (AB074915)722454.99170767411470
 Human HEV4d (AJ272108) 723254.425170765811268
 Swine HEV4e (AY723745)724054.525170767411470
 Human HEV4f (AB220974)724354.325170767411473
 Human HEV4g (AB108537)719355.09170667411442
 Swine HEV4h (GU119961)724055.126170767411469
 Swine HEV4i (DQ450072)723555.226170766012268
HEV-5
 Wild boar HEV5a (AB573435)725055.525170867411277
HEV-6
 Wild boar HEV6 (AB856243)724755.625170966011271
 Wild boar HEV 6a (AB602441) 724657.025170966011270
HEV-7
 Human HEV7 (KT818608) §722052.440169866011366
 DcHEV-178C (KJ496143) †722055.139169866011366
 DcHEV-180C (KJ496144) ‡721954.439169866011366
HEV-8
 BcHEV-12XJ (KX387865)722352.726170466011365
 BcHEV-48XJ (KX387866)722353.026170466011365
 BcHEV-62XJ (KX387867)721253.115170466011372
Orthohepevirus B
Avian HEV genotype 1 (AM943647) §≥6627 55.1NA ≥1531 60687123
Avian HEV genotype 2 (AY535004) 665455.524153160687127
Avian HEV genotype 3 (AM943646) ≥6631 55.6NA153260687126
Avian HEV novel unclassified genotype (JN997392) § ≥6543 55.7NA≥151560687 NA
Orthohepevirus C
Germany rat HEV (GU345042)694857.810163664410265
Vietnam rat HEV (JX120573) 692756.610162964410265
Ferret HEV (JN998606) 684153.812159665410865
Orthohepevirus D
Bat HEV (JQ001749) 676751.833158063713777
Piscihepevirus A
Cutthroat trout HEV (HQ731075) 726949.7100170763422576
* HEV, hepatitis E virus; UTR, untranslated region; ORF, open reading frame; BcHEV, HEV from Bactrian camel; DcHEV, HEV from dromedary camel; NA, not available because of incomplete genome; † Assuming the third AUG of ORF2 is the start codon; ‡ Assuming the third AUG of ORF3 is the start codon; § Near-complete genome.
Table
Table 3. p-Distance of the three BcHEV strains and other genotypes of HEV based on amino acid of ORF1/ORF2 excluding HVR region *.
Table 3. p-Distance of the three BcHEV strains and other genotypes of HEV based on amino acid of ORF1/ORF2 excluding HVR region *.
HEV Genotypes/Strains (GenBank Accession No.)p-Distance with Strain
BcHEV-12XJBcHEV-48XJBcHEV-62XJ
HEV-8
 BcHEV-12XJ-0.0110.009
 BcHEV-48XJ0.011-0.006
 BcHEV-62XJ0.0090.006-
HEV-1
 Human HEV subtype 1a (M73218)0.1430.1430.141
 Human HEV subtype 1b (D11092)0.1410.1420.140
 Human HEV subtype 1c (X98292)0.1400.1400.139
 Human HEV subtype 1d (AY230202)0.1390.1380.136
 Human HEV subtype 1f (JF443721)0.1430.1430.141
HEV-2
 Human HEV subtype 2a (M74506) †0.1560.1560.155
HEV-3
 Swine HEV subtype 3a (AF082843)0.1060.1050.106
 Human HEV subtype 3b (AP003430)0.1030.1030.104
 Wild boar HEV subtype 3c (FJ705359)0.1000.1000.101
 Swine HEV subtype 3e (AB248521)0.1040.1050.105
 Human HEV subtype 3f (AB369687)0.1050.1050.105
 Swine HEV subtype 3g (AF455784)0.1030.1050.105
 Wild boar HEV subtype 3i (FJ998008) †0.1010.1010.102
 Swine HEV subtype 3j (AY115488)0.1090.1090.110
 Rabbit HEV subtype 3ra (FJ906895)0.1320.1330.132
HEV-4
 Human HEV subtype 4a (AB197673)0.1220.1210.120
 Swine HEV subtype 4b (DQ279091)0.1240.1210.120
 Human HEV subtype 4c (AB074915)0.1230.1210.120
 Human HEV subtype 4d (AJ272108)0.1270.1250.124
 Swine HEV subtype 4e (AY723745)0.1200.1190.119
 Human HEV subtype 4f (AB220974)0.1270.1250.124
 Human HEV subtype 4g (AB108537)0.1210.1190.118
 Swine HEV subtype 4h (GU119961)0.1340.1320.131
 Swine HEV subtype 4i (DQ450072)0.1320.1300.129
HEV-5
 Wild boar HEV subtype 5a (AB573435)0.1390.1400.140
HEV-6
 Wild boar HEV 6 (AB856243)0.1390.1400.139
 Wild boar HEV subtype 6a (AB602441)0.1470.1490.148
HEV-7
 DcHEV 7 (KJ496144)0.1080.1070.106
 Human HEV 7 (KT818608) †0.1080.1070.105
 DcHEV subtype 7a (KJ496143)0.1100.1090.108
* HEV, hepatitis E virus; BcHEV, HEV from Bactrian camel; DcHEV, HEV from dromedary camel; ORF, open reading frame; HVR, hypervariable region; † Near-complete genome.

Share and Cite

MDPI and ACS Style

Sridhar, S.; Teng, J.L.L.; Chiu, T.-H.; Lau, S.K.P.; Woo, P.C.Y. Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants. Int. J. Mol. Sci. 2017, 18, 869. https://doi.org/10.3390/ijms18040869

AMA Style

Sridhar S, Teng JLL, Chiu T-H, Lau SKP, Woo PCY. Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants. International Journal of Molecular Sciences. 2017; 18(4):869. https://doi.org/10.3390/ijms18040869

Chicago/Turabian Style

Sridhar, Siddharth, Jade L. L. Teng, Tsz-Ho Chiu, Susanna K. P. Lau, and Patrick C. Y. Woo. 2017. "Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants" International Journal of Molecular Sciences 18, no. 4: 869. https://doi.org/10.3390/ijms18040869

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop